BeiGene: a Vast Opportunity Lies Ahead – But We Remain Cautious
BeiGene, a leader in China's novel pharmaceutical industry, recently received approval in Kuwait, Bahrain, and Qatar for its medication BRUKINSA (zanubrutinib). Previous contracts with major biopharma have produced substantial licensing income, but they did not lessen BeiGene's financial burden.
Jun 24, 2022 12:13 PM
Manufacturing Glass for the Automobile Industry: Fuyao Group
You may remember Fuyao from the 2019 Netflix documentary, 'American Factory.' While the documentary lays out the story of the Chinese company’s foray into America based on social issues, here you will find out about the business side.
May 27, 2020 07:45 PM